ArticleFrontiers in oncology2023

The evolution of minimal residual disease: key insights based on a bibliometric visualization analysis from 2002 to 2022.

Zhengyu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.